Total medical devices industry cross border deals worth $1.2bn were announced globally for September 2021, with the $538m acquisition of Itamar Medical being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 90.9% over the previous month of $13.23bn and a drop of 82.3% when compared with the last 12-month average of $6.84bn.

In terms of number of cross border deals, the sector saw a drop of 26.79% with 41 deals in September 2021 when compared to the last 12-month average of 56 deals.

In value terms, Middle East and Africa led the activity with cross border deals worth $538m in September 2021.

medical devices industry cross border deals in September 2021: Top deals

The top five cross border deals accounted for 74.7% of the overall value during September 2021.

The combined value of the top five cross border deals stood at $903m, against the overall value of $1.2bn recorded for the month.

The top five medical devices industry cross border deals of September 2021 tracked by GlobalData were:

1) Zoll Medical $538m acquisition deal with Itamar Medical

2) The $150m venture financing of Mammoth Biosciences by Decheng Capital,Foresite Capital Management,Greenspring Associates,Mayfield Fund,NFX partners,Plum Alley Investments,Redmile Group,Senator Investment Group and Sixth Street Partners

3) BlackRock,Endeavour Vision,Farallon Capital Management,Marshall Wace,MVM Partners,Novo Ventures (US),RTW Investments,Soleus Capital Management,venBio and Vivo Capital $102m venture financing deal with INBRACE

4) The $58m venture financing of Owlstone Medical by Horizon Ventures

5) Arboretum Ventures,Coloplast,H2Oey Ventures,Solas Bioventures and Tonkawa $55m venture financing deal with Francis Medical